Creates a steady caloric deficit Through glucose excretion, patients taking Invokana may burn up to an extra 360kcal per day. Activates nutrient-sensing longevity pathways By mimicking caloric restriction, Invokana may activate mTOR, AMPK, and SIRT1. Broad longevity benefits Modulating these longevity pathways may offer broad longevity potential, such as reduced risk of heart disease, improved kidney and liver health, better cognitive function, and moderate weight loss. What to expect 1 Day With the first dose, SGLT2 Inhibitors may help flush up to 80g of excess sugar a day, potentially reducing toxic glucose buildup and kickstarting a metabolic reset
spine surg relat res
GLP-1 medications like semaglutide are not a moral decision, a shortcut, or a failure of willpower
It may also be a good option for those exposed to environmental stressors, intense physical activity, or everyday oxidative stress
A Some patients may notice benefits even after a single treatment